# A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis

> **NCT02780388** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 57 (actual)

## Conditions studied

- Adult Onset Rheumatoid Arthritis

## Interventions

- **DRUG:** VIB4920
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02780388
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-12
- **Primary completion:** 2018-05-21
- **Final completion:** 2018-08-09
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780388, "A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02780388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*